Log In
BCIQ
Print this Print this
 

Human papillomavirus (HPV) antigens

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Human papillomavirus (HPV) antigens

BCIQ
Print ChartPrint this
Phase II, 1 Phase II, 2 Phase I/II, 2 Phase I, 1 Preclinical, 2 Preclinical, 2
Phase of DevelopmentPreclinicalPhase IPhase I/IIPhase II
Cancer

2

-

2

2

Infectious

2

1

-

1




 Products Targeting Human papillomavirus (HPV) antigens
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

$27.5M

$700.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/10/2015

Undisclosed

$27.5M

$700.0M

06/22/2015

0

0

0

Get a free BioCentury Trial today